The prospective preventative HIV vaccine based on modified poliovirus

被引:0
|
作者
Zhang, Yang-de [1 ]
Lu, Xiao-lin [1 ]
Li, Nian-feng [1 ]
机构
[1] Cent S Univ, Inst Biomed Engn, Changsha 410008, Hunan, Peoples R China
关键词
D O I
10.1016/j.mehy.2006.07.062
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In order to control HIV pandemic, many vaccines are invented. Although none first verified its efficacy in clinic, we hypothesize that HIV vaccine based on poliovirus is potential to develop the promising one, because it can elicit the broad immune response including the main mucosal, humoral and cellular reaction. However, the viral neural virulence is one major concern. The attenuated Sabin strain is a better candidate. White partial poliovirus genes are replaced by HIV antigen genes, the defective interfering particle will fail to produce progeny virions, which may further ensure its security. Although the vaccinal immune efficacy was verified in some similar animal experiments based on poliovirus to express the exogenous genes, more animal and clinical immune trials about HIV-poliovirus chimeric minireplicons are to be carried out and the hypotheses are to be validated. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1258 / 1261
页数:4
相关论文
共 50 条
  • [41] Vaccine Poliovirus Shedding and Immune Response to Oral Polio Vaccine in HIV-Infected and -Uninfected Zimbabwean Infants
    Troy, Stephanie B.
    Musingwini, Georgina
    Halpern, Meira S.
    Huang, ChunHong
    Stranix-Chibanda, Lynda
    Kouiavskaia, Diana
    Shetty, Avinash K.
    Chumakov, Konstantin
    Nathoo, Kusum
    Maldonado, Yvonne A.
    JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (04): : 672 - 678
  • [44] Poliomyelitis prevention: Recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine
    Halsey, NA
    Chesney, PJ
    Gerber, MA
    Gromisch, DS
    Kohl, S
    Marcy, SM
    Marks, MI
    Murray, DL
    Overall, JC
    Pickering, LK
    Whitley, RJ
    Yogev, R
    Peter, G
    Hall, CB
    Breiman, R
    Hardegree, MC
    Jacobs, RF
    Orenstein, WA
    Rabinovich, NR
    Schwartz, B
    PEDIATRICS, 1997, 99 (02) : 300 - 305
  • [45] Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016
    Hampton, Lee M.
    Farrell, Margaret
    Ramirez-Gonzalez, Alejandro
    Menning, Lisa
    Shendale, Stephanie
    Lewis, Ian
    Rubin, Jennifer
    Garon, Julie
    Harris, Jennifer
    Hyde, Terri
    Wassilak, Steven
    Patel, Manish
    Nandy, Robin
    Chang-Blanc, Diana
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2016, 65 (35): : 934 - 938
  • [46] Environmental poliovirus surveillance during oral poliovirus vaccine and inactivated poliovirus vaccine use in córdoba Province, Argentina
    Agence de Médecine Préventive, Paris, France
    不详
    不详
    不详
    不详
    Appl. Environ. Microbiol., 5 (1395-1401):
  • [47] New poliovirus vaccine schedules
    Zhang, Qian
    Leppold, Claire
    Shao, Yueqin
    Mura, Yuka
    Tanimoto, Tetsuya
    LANCET, 2016, 388 (10059): : 2477 - 2478
  • [48] Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: Results of a national survey
    Starace, F
    Wagner, TM
    Luzi, AM
    Cafaro, L
    Gallo, P
    Rezza, G
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2006, 18 (01): : 66 - 72
  • [49] POLIOVIRUS ANTIGEN CHIMERAS - A NOVEL-APPROACH TO HIV-1 VACCINE DEVELOPMENT
    EVANS, DJ
    MCKEATING, J
    BURKE, KL
    MEREDITH, JM
    FERGUSON, M
    MINOR, PD
    WEISS, RA
    ALMOND, JW
    VACCINES FOR SEXUALLY TRANSMITTED DISEASES, 1989, : 263 - 268
  • [50] Immune responses to oral poliovirus vaccine in HIV-exposed uninfected Zimbabwean infants
    Church, James A.
    Rukobo, Sandra
    Govha, Margaret
    Carmolli, Marya P.
    Diehl, Sean A.
    Chasekwa, Bernard
    Ntozini, Robert
    Mutasa, Kuda
    Humphrey, Jean H.
    Kirkpatrick, Beth D.
    Prendergast, Andrew J.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (11) : 2543 - 2547